Market Research Report
Pharmaceuticals Market in Turkey 2011-2015
|Published by||TechNavio (Infiniti Research Ltd.)||Product code||248659|
|Published||Content info||51 Pages
|Pharmaceuticals Market in Turkey 2011-2015|
|Published: August 9, 2012||Content info: 51 Pages||
This publication has been discontinued on November 12, 2015.
TechNavio's analysts forecast the Pharmaceuticals market in Turkey to grow at a CAGR of 14.5 percent over the period 2011-2015. One of the key factors contributing to this market growth is the adoption of the Healthcare Transformation Program in Turkey. The Pharmaceuticals market in Turkey has also been witnessing the entry of foreign players. However, the low per capita spending on healthcare could pose a challenge to the growth of this market.
TechNavio's report, the Pharmaceuticals Market in Turkey 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report focuses on Turkey; it also covers Pharmaceuticals market landscape, and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include Abdi Ibrahim, Bilim Pharmaceuticals, Novartis AG, and Pfizer Inc.
Other vendors mentioned in the report: Abbott Laboratories, Aliraif Pharmaceutical, AstraZeneca plc, Aventis Pharma Ltd, Bayer AG, Biofarma Pharmaceutical, Deva Pharmaceuticals Inc., Eastpharma Ltd., Eczacibasi Pharmaceuticals, GlaxoSmithKline plc, Menarini Raunaq Pharma Ltd, Merck & Co Inc, Mustafa Nevzat Pharmaceuticals, Nobel llac, Roche Diagnostics, Sanofi S.A., Sanovel Pharmaceuticals Inc., and Santa Farma Pharmaceuticals.
You can request one free hour of analyst time when you purchase this report. Details provided within the report.